Network pharmacology-based exploration of the synergistic efficacy and detoxification mechanisms of Tripterygium wilfordii and Epimedium brevicornum in treating rheumatoid arthritis

Abstract

Abstract:

Rheumatoid arthritis (RA) is a chronic autoimmune disease with limited therapeutic options. The herbal compatibility of Tripterygium wilfordii Hook. f. (Leigongteng, LGT) and Epimedium brevicornum Maxim. (Yinyanghuo, YYH), widely used in Traditional Chinese Medicine, has shown promising efficacy in RA treatment, yet its synergistic mechanisms and hepatoprotective effects remain unclear. In this study, we systematically investigated the therapeutic and hepatotoxicity-attenuating mechanisms of LGT-YYH using integrated network pharmacology and molecular docking approaches. Bioactive compounds and corresponding targets from LGT and YYH were retrieved from the TCMSP database, while RA- and hepatotoxicity-related targets were collected from public databases and microarray datasets. Protein-protein interaction networks, hub protein targets identification, and functional enrichment analyses revealed that 65 LGT and 26 YYH bioactive compounds collectively interact with 527 RA-related targets, with hub targets including PTPN11, SRC, EGFR, MAPK1, and MAPK8 central to the therapeutic network. KEGG enrichment highlighted the MAPK signaling pathway as a key mechanism of anti-RA activity. Furthermore, 243 targets were associated with LGT-induced hepatotoxicity, and YYH components, particularly icariin, kaempferol, and epimedin B, exhibited binding to hepatotoxicity-related targets such as AKT1 and ESR1, suggesting a hepatoprotective role via the AKT1-ESR1-Nrf2 axis. These findings indicate that LGT-YYH exerts synergistic anti-RA effects by modulating MAPK-related signaling while YYH components may mitigate LGT-induced hepatotoxicity, exemplifying the TCM principle of enhancing therapeutic efficacy while reducing toxicity.

Key words:

Tripterygium wilfordii, Epimedium brevicornum, rheumatoid arthritis, hepatoprotection, synergistic effect, network pharmacology, molecular docking

Yuhang Wang, Boyan Shen, Yuanqing Li, Guodong Yao.

Network pharmacology-based exploration of the synergistic efficacy and detoxification mechanisms of Tripterygium wilfordii and Epimedium brevicornum in treating rheumatoid arthritis

[J]. Asian Journal of Traditional Medicines, 2026, 21(2): 63-83.

Trendmd

[1]	Wanying Ma, Yuanqing Li, Simeng Ding, Guodong Yao. Synergistic action of the Daphnes Cortex and Liquorice Root herb pair in rheumatoid arthritis treatment: A network pharmacology strategy [J]. Asian Journal of Traditional Medicines, 2026, 21(1): 1-14.
[2]	Yijie Yin, Guixin Pan, Hua Jin, Xixi Wang, Yi Sun, Tonghua Yang, Tao Shen, Yalian Sa. Exploring the potential mechanism of drug pair Salviae Miltiorrhizae Radix et Rhizoma and Notoginseng Radix et Rhizoma in the treatment of thrombosis after polycythemia vera by network pharmacology [J]. Asian Journal of Traditional Medicines, 2025, 20(3): 105-120.
[3]	Liqi Cao, Tingting Chen, Chen Liu, Yueru Li, Xiaoqiu Liu, Xiajing Xu, Yingni Pan. Discovery of quality marker and study on its pharmacodynamic differences in antirheumatoid arthritis in the three original plants of Clematidis Radix et Rhizoma [J]. Asian Journal of Traditional Medicines, 2025, 20(2): 49-64.

Asian Journal
Of Traditional Medicines